von Willebrand factor in iris vasculature of glaucoma patients
- PMID: 24954072
- PMCID: PMC4072563
- DOI: 10.12659/MSM.890176
von Willebrand factor in iris vasculature of glaucoma patients
Abstract
Background: Previous reports have indicated the role of endothelium disturbances, as expressed by von Willebrand factor (vWF) release, in pathophysiology of glaucoma. The objective of this study was to investigate the vWF expression in iris vasculature of patients with primary open-angle glaucoma (POAG).
Material and methods: Immunohistochemistry of vWF expression was performed on cryostat sections of samples collected at the time of peripheral iridectomy and controls collected from dead donors.
Results: Twenty-seven Caucasians age 66.6±3.7 with 5.8±3.7-year history of treated PAOG and 10 controls age 62.2±1.92 with no history of glaucoma. The percentage of patients who presented normal and up-regulation of vWF phenotype expression differed statistically between examined and control groups: 48% versus 100% (p=0.035, chi-square test with Yates' correction). Sex, age, glaucoma duration, and visual field quantitative indices had no impact on vWF expression. A significant correlation between mean pre-surgery intraocular pressure and vWF expression was found (Spearman r=0.42, p=0.03).
Conclusions: Considering the results, it may be suggested that vWF is actively involved in the pathophysiology of glaucoma.
Figures
Similar articles
-
Inducible and endothelial nitric synthetase expression and nitrotyrosine accumulation in iris vasculature of patients with primary open-angle glaucoma: a pilot study.Med Sci Monit. 2015 Jan 7;21:76-81. doi: 10.12659/MSM.891177. Med Sci Monit. 2015. PMID: 25564962 Free PMC article.
-
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.Br J Ophthalmol. 2002 Nov;86(11):1299-302. doi: 10.1136/bjo.86.11.1299. Br J Ophthalmol. 2002. PMID: 12386093 Free PMC article.
-
Distinct iris gene expression profiles of primary angle closure glaucoma and primary open angle glaucoma and their interaction with ocular biometric parameters.Clin Exp Ophthalmol. 2016 Nov;44(8):684-692. doi: 10.1111/ceo.12743. Epub 2016 May 2. Clin Exp Ophthalmol. 2016. PMID: 26988898 Free PMC article.
-
Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1601-9. doi: 10.1007/s00417-010-1406-x. Epub 2010 Jun 4. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20524132
-
Toward Personalized Treatment for Patients with Low von Willebrand Factor and Quantitative von Willebrand Disease.Semin Thromb Hemost. 2021 Mar;47(2):192-200. doi: 10.1055/s-0041-1722864. Epub 2021 Feb 26. Semin Thromb Hemost. 2021. PMID: 33636750 Review.
Cited by
-
Genome-wide association analyses identify new loci influencing intraocular pressure.Hum Mol Genet. 2018 Jun 15;27(12):2205-2213. doi: 10.1093/hmg/ddy111. Hum Mol Genet. 2018. PMID: 29617998 Free PMC article.
References
-
- Rokicki W, Dorecka M, Romaniuk W. Retinal ganglion cells death in glaucoma-mechanism and potential treatment. Part I and II. Klin Oczna. 2007;109:349–55. - PubMed
-
- Findl O, Rainer G, Dallinger S, et al. Assessment of optic disc blood flow in patients with open-angle glaucoma. Am J Ophthalmol. 2000;130:589–96. - PubMed
-
- Fuchsjäger-Mayrl G, Wally B, Georgopoulos M, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 2004;45:834–39. - PubMed
-
- Resch H, Garhofer G, Fuchsjäger-Mayrl G, et al. Endothelial dysfunction in glaucoma. Acta Ophthalmol. 2009;87:4–12. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous